LGP Stock Overview
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Little Green Pharma Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.12 |
| 52 Week High | AU$0.17 |
| 52 Week Low | AU$0.076 |
| Beta | 1.01 |
| 1 Month Change | -4.00% |
| 3 Month Change | 0% |
| 1 Year Change | -17.24% |
| 3 Year Change | -77.57% |
| 5 Year Change | n/a |
| Change since IPO | -65.71% |
Recent News & Updates
Is Little Green Pharma (ASX:LGP) Using Debt Sensibly?
Jan 17
Improved Revenues Required Before Little Green Pharma Ltd (ASX:LGP) Shares Find Their Feet
Nov 19Recent updates
Is Little Green Pharma (ASX:LGP) Using Debt Sensibly?
Jan 17Improved Revenues Required Before Little Green Pharma Ltd (ASX:LGP) Shares Find Their Feet
Nov 19The Market Doesn't Like What It Sees From Little Green Pharma Ltd's (ASX:LGP) Revenues Yet As Shares Tumble 27%
Jun 30Estimating The Fair Value Of Little Green Pharma Ltd (ASX:LGP)
Jun 17Little Green Pharma (ASX:LGP) Has Debt But No Earnings; Should You Worry?
Mar 05Not Many Are Piling Into Little Green Pharma Ltd (ASX:LGP) Just Yet
Nov 01A Look At The Intrinsic Value Of Little Green Pharma Ltd (ASX:LGP)
May 08Statutory Earnings May Not Be The Best Way To Understand Little Green Pharma's (ASX:LGP) True Position
Sep 06What Type Of Shareholders Make Up Little Green Pharma Ltd's (ASX:LGP) Share Registry?
Feb 11
Shareholder Returns
| LGP | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -2.8% | 1.3% |
| 1Y | -17.2% | -5.5% | 10.3% |
Return vs Industry: LGP underperformed the Australian Pharmaceuticals industry which returned -5.5% over the past year.
Return vs Market: LGP underperformed the Australian Market which returned 10.3% over the past year.
Price Volatility
| LGP volatility | |
|---|---|
| LGP Average Weekly Movement | 12.7% |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in AU Market | 16.4% |
| 10% least volatile stocks in AU Market | 2.9% |
Stable Share Price: LGP's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: LGP's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 94 | Paul Long | www.littlegreenpharma.com |
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.
Little Green Pharma Ltd Fundamentals Summary
| LGP fundamental statistics | |
|---|---|
| Market cap | AU$33.32m |
| Earnings (TTM) | -AU$9.43m |
| Revenue (TTM) | AU$28.88m |
1.3x
P/S Ratio-3.9x
P/E RatioIs LGP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LGP income statement (TTM) | |
|---|---|
| Revenue | AU$28.88m |
| Cost of Revenue | AU$16.09m |
| Gross Profit | AU$12.79m |
| Other Expenses | AU$22.22m |
| Earnings | -AU$9.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.031 |
| Gross Margin | 44.27% |
| Net Profit Margin | -32.65% |
| Debt/Equity Ratio | 4.5% |
How did LGP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 07:49 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Little Green Pharma Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Cameron Bell | Canaccord Genuity |